Herantis Pharma Oyj
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
HRTIS | ST
Overview
Corporate Details
- ISIN(s):
- FI4000087861
- LEI:
- 743700W4CQVYAT3WKK38
- Country:
- Finland
- Address:
- Bertel Jungin Aukio 1, FI-02600 ESPOO
- Website:
- https://herantis.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Herantis Pharma is a clinical-stage biotechnology company focused on developing disease-modifying therapies for neurodegenerative conditions, with a primary emphasis on Parkinson's disease. The company's mission is to address significant unmet medical needs by creating treatments designed to stop or reverse disease progression. Its research and development efforts are centered on its proprietary technology platform, which includes lead drug candidates like HER-096, a therapy based on the Cerebral Dopamine Neurotrophic Factor (CDNF) protein.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Herantis Pharma Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Herantis Pharma Oyj via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
